Novel Enantiocomplementary C2-Symmetric Chiral Bis(imidazoline) Ligands
COMMUNICATIONS
Achiwa, Synlett 1997, 783–785; c) A. Bastero, A. Ruiz,
C. Claver, S. Castillón, Eur. J. Inorg. Chem. 2001,
3009–3011; d) A. J. Davenport, D. L. Davies, J. Faw-
cett, D. R. Russell, J. Chem. Soc. Perkin Trans. 1 2001,
1500–1503; e) F. Menges, M. Neuburger, A. Pfaltz,
Org. Lett. 2002, 4, 4713–4716; f) A. Bastero, A. Ruiz,
C. Claver, B. Milani E. Zangrando, Organometallics
2002, 21, 5820–5829; g) M. Casey, M. P. Smyth, Synlett
2003, 102–106; h) C. A. Busacca, D. Grossbach, R. C.
So, E. M. OꢁBrien, E. M. Spinelli, Org. Lett. 2003, 5,
595–598; i) A. Bastero, C. Claver, A. Ruiz, S. Castillón,
E. Daura, C. Bo, E. Zangrando, Chem. Eur. J. 2004, 10,
3747–3760; j) J. Xu, Y. Guan, S. Yang, Y. Ng, G. Peh,
C. Tan, Chem. Asian J. 2006, 1, 724–729; k) D. F. Fisch-
er, Z. Xin, R. Peters, Angew. Chem. 2007, 119, 7848–
7851; Angew. Chem. Int. Ed. 2007, 46, 7704–7707.
[4] a) S. Cacchi, G. Fabrizi, Chem. Rev. 2005, 105, 2873–
2920; b) G. R. Humphrey, J. T. Kuethe, Chem. Rev.
2006, 106, 2875–2911.
Experimental Section
Typical Procedure for the Friedel–Crafts Reaction
using the Phebim Ligand: (2R)-Ethyl 3,3,3-Trifluoro-
2-hydroxy-2-(indol-3-yl)propionate [(R)-3a]
To a mixture of CuACHTRE(UNG OTf)2 (2.5 mg, 6.91 mmol), 2c (6.3 mg,
7.60 mmol) and molecular sieves 4 (24 mg) in CH2Cl2
(1.0 mL) was added 1 (20.2 mL, 0.152 mmol) at À788C.
After stirring for 30 min, a solution of indole (16.2 mg,
0.138 mmol) in CH2Cl2 (1.0 mL) was slowly added. After
disappearance of indole in the reaction mixture on TLC, the
solvent was removed under reduced pressure to give a resi-
due which was purified by column chromatography (hexane/
Et2O=55:45) giving 3a as a white solid; yield: 37.6 mg
(95%).
Acknowledgements
[5] The products are known to act as an inhibitor of amy-
loid fibrillogenesis for Alzheimerꢁs disease; see: M.
Tçrçk, M. Abid, S. C. Mhadgut, B. Tçrçk, Biochemistry
2006, 45, 5377–5383.
This work was supported by the Mitsubishi Chemical Corpo-
ration Fund. We are grateful to Central Glass Co. for a gift of
1.
[6] For a recent review on asymmetric F-C alkylations
using chiral Lewis acids, see: a) M. Bandini, A. Mello-
ni, A. Umani-Ronchi, Angew. Chem. 2004, 116, 560–
566; Angew. Chem. Int. Ed. 2004, 43, 550–556, and ref-
erences cited therein. For asymmetric F-C alkylations
of indole derivatives with trifluoropyruvate using chiral
Lewis acids, see: b) N. Gathergood, W. Zhuang, K. A.
Jørgensen, J. Am. Chem. Soc. 2000, 122, 12517–12522;
c) W. Zhuang, N. Gathergood, R. G. Hazell, K. A. Jør-
gensen, J. Org. Chem. 2001, 66, 1009–1013; d) K. A.
Jørgensen, Synthesis 2003, 1117–1125; e) M. P. A. Lyle,
N. D. Draper, P. D. Wilson, Org. Lett. 2005, 7, 901–904.
For recent asymmetric F-C alkylations with carbonyl
compounds, see: f) J. Zhao, L. Liu, Y. Sui, Y. Liu, D.
Wang, Y. Chen, Org. Lett. 2006, 8, 6127–6130; g) H.
Dong, H. Lu, L. Lu, C. Chen, W. Xiao, Adv. Synth.
Catal. 2007, 349, 1597–1603. For F-C alkylations with
other electrophiles using chiral Lewis acids, see: h) Y.
Jia, J. Xie, H. Duan, L. Wang, Q. Zhou, Org. Lett.
2006, 8, 1621–1624; i) R. Rasappan, M. Hager, A. Gis-
sibl, O. Reiser, Org. Lett. 2006, 8, 6099–6102; j) H.
Yang, Y. Hong, S. Kim, Org. Lett. 2007, 9, 2281–2284;
k) G. Blay, I. Fernꢂndez, J. R. Pedro, C. Vila, Org. Lett.
2007, 9, 2601–2607.
[7] For asymmetric F-C alkylations of indole derivatives
with trifluoropyruvate using organocatalysts, see: a) B.
Tçrçk, M. Abid, G. London, J. Esquibel, M. Tçrçk,
S. C. Mhadgut, P. Yan, G. K. S. Prakash, Angew. Chem.
2005, 117, 3146–3149; Angew. Chem. Int. Ed. 2005, 44,
3086–3089. For organocatalyzed asymmetric F-C alky-
lations, see review ref.[6a] For recent organocatalyzed
asymmetric F-C alkylations, see: b) H. Li, Y. Wang, L.
Deng, Org. Lett. 2006, 8, 4063–4065. For F-C alkyla-
tions with imines, see: c) D. Uraguchi, K. Sorimachi,
M. Terada, J. Am. Chem. Soc. 2004, 126, 11804–11805;
d) Y.-Q. Wang, J. Song, R. Hong, H. Li, L. Deng, J.
Am. Chem. Soc. 2006, 128, 8156–8157; e) M. Terada,
K. Sorimachi, J. Am. Chem. Soc. 2007, 129, 292–293;
f) Q. Kang, Z. Zhao, S. You, J. Am. Chem. Soc. 2007,
References
[1] For recent reviews, see: a) K. A. Jørgensen, M. Johann-
sen, S. Yao, H. Audrain, J. Thornauge, Acc. Chem. Res.
1999, 32, 605–613; b) A. K. Ghosh, P. Mathivanan, J.
Cappiello, Tetrahedron: Asymmetry 1998, 9, 1–45;
c) G. Desimoni, G. Faita, P. Quadrelli, Chem. Rev.
2003, 103, 3119–3154; d) G. Desimoni, G. Faita, K. A.
Jørgensen, Chem. Rev. 2006, 106, 3561–3651.
[2] a) J. Dupont, G. Ebeling, M. R. Delgado, C. S. Consor-
ti, R. Burrow, D. H. Farrar, A. J. Lough, Inorg. Chem.
Commun. 2001, 4, 471–474; b) S. B. Tsogoeva, G.
Dürner, M. Bolte, M. W. Gçbel, Eur. J. Org. Chem.
2003, 1661–1664; c) N. A. Boland, M. Casey, S. J.
Hynes, J. W. Matthews, H. Müller-Bunz, P. Wilkes, Org.
Biomol. Chem. 2004, 2, 1995–2002; d) S. Bhor, G. Anil-
kumar, M. K. Tse, M. Klawonn, C. Dçbler, B. Bitter-
lich, A. Grotevendt, M. Beller, Org. Lett. 2005, 7,
3393–3396; e) T. Arai, T. Mizukami, N. Yokoyama, D.
Nakazato, A. Yanagisawa, Synlett 2005, 2670–2672;
f) G. Anilkumar, S. Bhor, M. K. Tse, M. Klawonn, B.
Bitterlich, M. Beller, Tetrahedron: Asymmetry 2005, 16,
3536–3561; g) B. Ramalingam, M. Neuburger, A.
Pfaltz, Synthesis 2007, 572–582; h) K. Ma, J. You,
Chem. Eur. J. 2007, 13, 1863–1871; i) T. Arai, T. Mizu-
kami, A. Yanagisawa, Org. Lett. 2007, 9, 1145–1147;
j) S. Enthaler, B. Hagemann, S. Bhor, G. Anilkumar,
M. K. Tse, B. Bitterlich, K. Junge, G. Erre, M. Beller,
Adv. Synth. Catal. 2007, 349, 853–860; k) D. Akalay, G.
Dürner, J. W. Bats, M. Bolte, M. W. Gçbel, J. Org.
Chem. 2007, 72, 5618–5624; l) S. Jautze, P. Seiler, R.
Peters, Chem. Eur. J. 2008, 14, 1430–1444.
[3] For reactions with monoimidazolines as chiral ligands,
see a) C. Botteghi, A. Schionato, G. Chelucci, H. Brun-
ner, A. Kürzinger, U. Obermann, J. Organomet. Chem.
1989, 370, 17–31; b) T. Morimoto, K. Tachibana, K.
Adv. Synth. Catal. 2008, 350, 1443 – 1448
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1447